These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 25485838)

  • 21. Genetics of Cushing's disease.
    Albani A; Theodoropoulou M; Reincke M
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):3-12. PubMed ID: 28850717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP8 mutation in Cushing's disease.
    Huang C; Shi Y; Zhao Y
    Oncotarget; 2015 Jul; 6(21):18240-1. PubMed ID: 26285834
    [No Abstract]   [Full Text] [Related]  

  • 23. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
    Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.
    Sbiera S; Tryfonidou MA; Weigand I; Grinwis GC; Broeckx B; Herterich S; Allolio B; Deutschbein T; Fassnacht M; Meij BP
    PLoS One; 2016; 11(12):e0169009. PubMed ID: 28005997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of Cushing's disease: from the lab to clinical practice.
    Theodoropoulou M; Reincke M
    Pituitary; 2022 Oct; 25(5):689-692. PubMed ID: 35852754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
    Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
    BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biophysical and structural insight into the USP8/14-3-3 interaction.
    Centorrino F; Ballone A; Wolter M; Ottmann C
    FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic
    Detomas M; Altieri B; Schlötelburg W; Appenzeller S; Schlaffer S; Coras R; Schirbel A; Wild V; Kroiss M; Sbiera S; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2021; 12():731579. PubMed ID: 34489873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
    Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
    Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
    Dufner A; Knobeloch KP
    Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.
    Kakihara K; Asamizu K; Moritsugu K; Kubo M; Kitaguchi T; Endo A; Kidera A; Ikeguchi M; Kato A; Komada M; Fukushima T
    Commun Biol; 2021 Nov; 4(1):1272. PubMed ID: 34750505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity.
    Shichi H; Fukuoka H; Kanzawa M; Yamamoto M; Yamamoto N; Suzuki M; Urai S; Matsumoto R; Kanie K; Fujita Y; Bando H; Iguchi G; Inoshita N; Yamada S; Takahashi Y; Ogawa W
    Pituitary; 2022 Jun; 25(3):496-507. PubMed ID: 35451730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.
    Albani A; Perez-Rivas LG; Tang S; Simon J; Lucia KE; Colón-Bolea P; Schopohl J; Roeber S; Buchfelder M; Rotermund R; Flitsch J; Thorsteinsdottir J; Herms J; Stalla G; Reincke M; Theodoropoulou M
    Endocr Relat Cancer; 2022 Aug; 29(8):503-511. PubMed ID: 35686696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing's Disease.
    Chen Z; Jia Q; Zhao Z; Zhang Q; Chen Y; Qiao N; Ye Z; Ji C; Zhang Y; He W; Shi C; Cai Y; Yao B; Han R; Wang Y; Shou X; Shen M; Cao X; Zhou X; Cheng H; Zhu J; Hu Y; Zhang Z; Ye H; Li Y; Li S; Wang Y; Ma Z; Ni T; Zhao Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2296-2306. PubMed ID: 35521682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic
    Pérez-Rivas LG; Theodoropoulou M; Puar TH; Fazel J; Stieg MR; Ferraù F; Assié G; Gadelha MR; Deutschbein T; Fragoso MC; Kusters B; Saeger W; Honegger J; Buchfelder M; Korbonits M; Bertherat J; Stalla GK; Hermus AR; Beuschlein F; Reincke M
    Eur J Endocrinol; 2018 Jan; 178(1):57-63. PubMed ID: 28982703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
    Chen J; Jian X; Deng S; Ma Z; Shou X; Shen Y; Zhang Q; Song Z; Li Z; Peng H; Peng C; Chen M; Luo C; Zhao D; Ye Z; Shen M; Zhang Y; Zhou J; Fahira A; Wang Y; Li S; Zhang Z; Ye H; Li Y; Shen J; Chen H; Tang F; Yao Z; Shi Z; Chen C; Xie L; Wang Y; Fu C; Mao Y; Zhou L; Gao D; Yan H; Zhao Y; Huang C; Shi Y
    Nat Commun; 2018 Aug; 9(1):3171. PubMed ID: 30093687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driver mutations in USP8 wild-type Cushing's disease.
    Sbiera S; Perez-Rivas LG; Taranets L; Weigand I; Flitsch J; Graf E; Monoranu CM; Saeger W; Hagel C; Honegger J; Assie G; Hermus AR; Stalla GK; Herterich S; Ronchi CL; Deutschbein T; Reincke M; Strom TM; Popov N; Theodoropoulou M; Fassnacht M
    Neuro Oncol; 2019 Oct; 21(10):1273-1283. PubMed ID: 31222332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis.
    Wanichi IQ; de Paula Mariani BM; Frassetto FP; Siqueira SAC; de Castro Musolino NR; Cunha-Neto MBC; Ochman G; Cescato VAS; Machado MC; Trarbach EB; Bronstein MD; Fragoso MCBV
    Pituitary; 2019 Aug; 22(4):435-442. PubMed ID: 31273566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.